德诺苏马布改善了与暴露于芳酶抑制剂的妇女骨折风险降低相关的骨骨评分
S Antonini1,2, R Pedersini3, M F Birtolo1,2
1Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, 20090, Pieve Emanuele, MI, Italy.
Journal of endocrinological investigation
|August 17, 2023
概括
在接受芳酶抑制剂 (AI) 治疗的妇女中,丁诺苏马布有效改善了TBS和降低了脊椎骨折风险. 双酸盐对TBS或骨折风险没有显著影响.
科学领域:
- 骨质疏松症研究 骨质疏松症研究
- 医学成像分析 医学成像分析
- 药理干预药理干预
背景情况:
- 脊椎骨评分 (TBS) 是评估骨结构和骨折风险的验证指标.
- 乳腺癌治疗中使用的芳酶抑制剂 (AI) 可以诱导骨质损失并增加骨折风险.
- 骨修饰剂在人工智能诱导的骨质疏松症中对TBS的影响尚未得到充分证实.
研究的目的:
- 评估德诺苏马布和双酸盐 (BP) 对人工智能诱导骨质疏松症妇女的TBS和脊椎骨折 (VF) 的影响.
- 为了确定TBS变化是否可以预测这个患者群体的骨折风险.
主要方法:
- 对241名早期乳腺癌患者接受人工智能治疗的女性进行了回顾性分析.
- 在基线和18-24个月后评估TBS,骨矿物密度 (BMD) 和VFs.
- 接受德诺苏马布,BP或没有骨活性治疗的组之间的比较.
主要成果:
- 代诺苏马布显著增加了TBS和降低了VF风险 (分别P < 0.001和P = 0.021).
- 与未接受治疗的女性相比,双酸盐并没有显著改变TBS或VF发病率.
- 降低TBS与事件VF相关,独立于BMD变化.
结论:
- 在接受AI治疗的妇女中,TBS变异是骨折风险的预测因素.
- 德诺苏马布在改善TBS和降低AI治疗早期的VF风险方面表现出有效性.
更多相关视频
06:59Author Spotlight: An Economic and Efficient Method for Quantitative Evaluation of Bone Microarchitecture in a Murine Osteoporosis Model
Published on: September 8, 2023
2.4K
07:12Semiautomated Longitudinal Microcomputed Tomography-based Quantitative Structural Analysis of a Nude Rat Osteoporosis-related Vertebral Fracture Model
Published on: September 28, 2017
8.2K
相关概念视频
Bone Disorders
3.7K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.7K
Bone Remodeling
38.4K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.4K
Hormones and Bone Tissue
2.7K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
2.7K
Osteoclasts in Bone Remodeling
3.0K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.0K
